Replimune REPL
NASDAQ REPL
$15.03 -0.26 (-1.70%)
As of: Sep 4, 2026 · 3:57 PM EDT

Replimune (REPL) Current Leases (2019 - 2026)

Replimune (REPL) posted Current Leases of $1.2 million for Q1 2026, down 4.53% sequentially from $1.2 million in Q4 2025, and down 2.2% YoY from $1.2 million in Q1 2025.

Analysis

Replimune (REPL) Current Leases (2019 - 2026) Analysis & Trends

Replimune has reported Current Leases for 8 years, with the latest figure at $1.2 million in Q1 2026.

  • Quarterly Current Leases fell 2.2% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 2.2% YoY) and the FY2026 annual result came in at $1.2 million, down 2.2% from the prior year.
  • Current Leases declined to $1.2 million in Q1 2026 per REPL's latest filing, from $1.2 million in the prior quarter.
  • Over five years, Current Leases peaked at $2.8 million in Q3 2025 and troughed at $1.0 million in Q3 2022.
  • A 5-year average of $1.9 million and a median of $1.2 million in 2025 frame the typical range for Current Leases.
  • The sharpest annual moves came in 2022 and 2023: Current Leases tumbled 59.14% in 2022, then jumped 167.27% in 2023.
  • Over 5 years, Current Leases stood at $1.0 million in 2022, then advanced by 11.93% to $1.2 million in 2023, then increased by 0.09% to $1.2 million in 2024, then rose by 4.21% to $1.2 million in 2025, then decreased by 4.53% to $1.2 million in 2026.
  • According to Business Quant data, Current Leases over the past three periods registered $1.2 million, $1.2 million, and $2.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 720.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 11.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 16.75 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 21.95 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 45.93 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.27 Mn
10 Replimune 1.46 Bn 1.46 Bn - 2.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.90 Mn
Mar 31, 2026 2.88 Mn
Dec 31, 2025 2.86 Mn
Sep 30, 2025 2.84 Mn
Jun 30, 2025 2.82 Mn
Mar 31, 2025 2.80 Mn
Dec 31, 2024 2.78 Mn
Sep 30, 2024 2.76 Mn
Jun 30, 2024 2.74 Mn
Mar 31, 2024 2.72 Mn
Dec 31, 2023 2.70 Mn
Sep 30, 2023 2.68 Mn
Jun 30, 2023 2.66 Mn
Mar 31, 2023 2.64 Mn
Dec 31, 2022 2.62 Mn
Sep 30, 2022 2.60 Mn
Jun 30, 2022 2.58 Mn
Mar 31, 2022 2.56 Mn
Dec 31, 2021 2.54 Mn
Sep 30, 2021 2.52 Mn